Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders
Sign Up to like & getrecommendations! Published in 2017 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2017.08.435
Abstract: Patients with Attention Deficit/Hyperactivity Disorder (ADHD) and comorbid Substance Use Disorders (SUD) are increasingly being treated with central stimulant medication despite limited evidence for its effectiveness. Lack of longitudinal follow-up studies of dosing and adverse… read more here.
Keywords: comorbid substance; deficit hyperactivity; hyperactivity disorder; methylphenidate doses ... See more keywords
Cost and Cost Savings of Navigation Services to Avoid Rehospitalization for a Comorbid Substance Use Disorder Population
Sign Up to like & getrecommendations! Published in 2022 at "Medical Care"
DOI: 10.1097/mlr.0000000000001743
Abstract: Background: A randomized clinical trial found that patient navigation for hospital patients with comorbid substance use disorders (SUDs) reduced emergency department (ED) and inpatient hospital utilization compared with treatment-as-usual. Objective: To compare the cost and… read more here.
Keywords: cost; patient navigation; cost savings; hospital ... See more keywords